This study further demonstrated that treatment with angiotensin II caused cardiac hypertrophy and myocardial fibrosis along with NOX4 upregulation and ROS production in control mice, and all these changes were much more aggravated in hNOX4 [33]. Here, NOX4 is linked to cardiac hypertrophy.